Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the production of selective serotonin reuptake inhibitors (SSRIs) and other central nervous system (CNS) active agents. Its chiral amine structure makes it valuable for asymmetric synthesis, where stereochemistry plays a critical role in drug efficacy and safety. Commonly employed in the development of antidepressants and anxiolytic drugs due to its ability to influence neurotransmitter activity. Also utilized in the preparation of enzyme inhibitors and receptor modulators in medicinal chemistry research. Its trifluoromethyl group enhances metabolic stability and lipophilicity, improving drug bioavailability.